AssistRx President and CEO Jeff Spafford lent his voice to Drug Channels—one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution system—to weigh in on how to combat the gross-to-net squeeze and increased competition with a technology-driven pharmacy platform that removes barriers to access, eliminates switching/substitution at the pharmacy and speeds the process.
